Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
Autor
Nicol, Thomas
Lefeuvre, Caroline
Serri, Orianne
Pivert, Adeline
Joubaud, Françoise
Dubée, Vincent
Kouatchet, Achille
Ducancelle, Alexandra
Lunel-Fabiani, Françoise
Le Guillou-Guillemette, Hélène